Q32 Bio (QTTB) announced the appointment of Adrien Sipos as interim chief medical officer. Sipos succeeds Jason Campagna who will be departing the company. Prior to joining Q32 Bio, Sipos served as president and chief medical officer at Praxico.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTTB: